• trauma

In a recent article by Sadek et al (Sadek E, et al. Emerg Med J 2024;41:162–7), we noted several incorrect statements and respectfully ask the authors to correct the following points:

1. In the introduction of their article (Sadek et al, p163),1 Sadek et al1 stated the following: “The costs of low dose and high dose of andexanet alfa are approximately $29 040 and $58 080, respectively.” The authors did not cite a reference and incorrectly stated the cost …